8.27
0.73%
0.06
시간 외 거래:
8.27
Theravance Biopharma Inc (TBPH) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
17.43%
14.50
|
17.57 | 15.69 | 13.75 | 10.42 |
Operating Expenses
|
8.00%
25.71
|
23.80 | 24.45 | 29.87 | 35.33 |
Interest Income/Expense |
0.96%
0.629
|
0.623 | 0.609 | 0.568 | 0.55 |
Benefits Costs and Expenses |
4.49%
24.91
|
26.07 | 24.64 | 29.39 | 32.51 |
Costs And Expenses |
4.49%
24.91
|
26.07 | 24.64 | 29.39 | 32.51 |
Operating Income/Loss |
79.60%
-11.21
|
-6.24 | -8.76 | -16.12 | -24.91 |
Income/Loss From Continuing Operations Before Tax |
22.23%
-10.40
|
-8.51 | -7.583 | -14.19 | -22.48 |
Income Tax Expense/Benefit, Deferred |
-0.513
|
- | - | - | - |
Income Tax Expense/Benefit |
63.88%
1.262
|
3.494 | 1.367 | 1.458 | -0.395 |
Income/Loss From Continuing Operations After Tax |
37.06%
-11.66
|
-8.51 | -8.95 | -15.64 | -22.09 |
Net Income/Loss
|
37.06%
-11.66
|
-8.51 | -8.95 | -15.64 | -22.09 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,534%
48.28
|
-1.984 | 52.36 | 56.68 | 62.93 |
Diluted Average Shares |
2,534%
48.28
|
-1.984 | 52.36 | 56.68 | 62.93 |
Basic Earnings Per Share |
41.18%
-0.24
|
-0.17 | -0.17 | -0.28 | -0.35 |
Diluted Earnings Per Share |
41.18%
-0.24
|
-0.17 | -0.17 | -0.28 | -0.35 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):